Cozza A, Chinig C, Filicetti E, Greco GI, Lappano R, Marinaro C, Muglia L, Soraci L, Corsonello A, Lattanzio F, Volpentesta M (2025) Effects of antidiabetic medications on the relationship between type 2 diabetes mellitus and cognitive impairment
Recent developments in therapeutic peptides for the glucagon-like peptide 1 and 2 receptors
Irritable bowel syndrome is a gastrointestinal disorder that is defined by the presence of a cluster of symptoms and signs, including cramping, abdominal pain, increased gas, altered bowel habits, food intolerance, and bloating (distention)
For a 165 pound runner, that translates to nearly 2,000 pounds of force with each stride
This remarkable peptide has been making waves in the field of medical weight loss, offering promising results to those seeking a healthier, more confident life